So the benefit is real, but it is indirect and it depends on whether you were low to begin with
Just thank you, from the bottom of my heart
We noted that for the purposes of the device pass-through evaluation process, CMS evaluates the nominated device that is the subject of an application to determine if the device meets the eligibility criteria described in 419.66
In this blog post, we will look at the pros and cons of each option so you can make an informed decision
Annals of Internal Medicine, 116(8), 609614
Commenters recommended that CMS use the lower of methodology to determine the eligibility cost threshold: Current methodology using the two times rule, OR The lowest GMC of significant procedures in the APC to which the code combination would be eligible for complexity adjustment